NVIDIA Introduces RTX Kit, Expanding Neural Rendering Capabilities
NVIDIA (NVDA, Financials) launched RTX Kit, a suite of AI-driven rendering technologies designed to enhance real-time graphics performance and efficiency.
Warning! GuruFocus has detected 3 Warning Signs with NVDA.
Combining many neural rendering components in the new toolkit lets developers use artificial intelligence for real-time ray tracing, texture reduction, and character rendering.
Currently housed on GitHub, RTX Kit combines numerous new technologies with NVIDIA's current rendering SDKs. According to the business, by means of AI-powered compression and approximation algorithms, the platform helps game creators build lifelike materials and maximize rendering speeds.
RTX Neural Shaders are among the main enhancements of RTX Kit as they enable neural networks to be implemented into shaders thus enhancing performance and lowering asset size. Another recently released technology, RTX Neural Texture Compression, employs artificial intelligence to compress textures, hence lowering VRAM utilization by up to eight times while preserving visual integrity. RTX Mega Geometry, which speeds BVH creation for path tracing large-scale scenes, and RTX Character Rendering, intended to improve the realism of digital people via AI-driven skin and hair rendering, are other features.
While DirectX support is anticipated in further versions, NVIDIA said Vulkan support is already available for neural shading applications. To further enhance picture quality in gaming and visualization uses, the business also emphasized its ongoing investment in real-time denoising, dynamic lighting, and global illumination technologies.
Following recent developments in DLSS 4 and Reflex 2, which maximize frame generation and latency reduction for the GeForce RTX 50 series, the debut of RTX Kit fits NVIDIA's larger drive to include AI in graphics processing.
This article first appeared on GuruFocus.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
UiPath (PATH) Price Target Lifted to $15 Following Strong Q1 Metrics
UiPath (PATH, Financials) got a lift from Wall Street after posting stronger-than-expected first-quarter results. RBC Capital raised its price target to $15 on Friday, maintaining a Sector Perform rating, with the stock last seen trading at $13.21. The company beat expectations on revenue and operating margins, while Annual Recurring Revenue also came in ahead of guidance. Warning! GuruFocus has detected 3 Warning Sign with PATH. UiPath's solid quarter was backed by an 82.6% gross margin and a current ratio of 2.95, signaling strong financial footing. Management raised full-year 2026 guidance, citing steady renewal rates and resilient performance in its Federal businesseven as macroeconomic uncertainty lingers. Analysts reacted with a mix of caution and optimism. BMO Capital lifted its target to $15.50, citing momentum in the deal pipeline. Mizuho and DA Davidson raised their targets to $14, pointing to solid execution and a successful product cycle, though both kept Neutral ratings. Needham stayed on Hold, flagging weaker net new ARR and retention metrics. KeyBanc maintained a Sector Weight rating, noting the early nature of automation adoption and macro concerns. With price targets now ranging from $10 to $17, the street remains split. Investors will be watching for follow-through in Q2 and beyond to see if UiPath can build on its momentum. Check insider trades. This article first appeared on GuruFocus.
Business Insider
3 hours ago
- Business Insider
How Will AMD Compete With Nvidia In China?
Advanced Micro Devices (AMD) isn't going to let rival graphics processing unit (GPU) maker Nvidia (NVDA) corner the Chinese artificial intelligence (AI) market without a fight. Instead, AMD has revealed a new custom GPU based on the Radeon AI Pro R9700 that will be sold to AI firms in China. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter AMD's new graphics card will compete with Nvidia's RTX 50 Series line being sold in China. However, this updated graphics card will likely be weaker than the commercial version that was sold in the U.S. This is due to President Donald Trump's strict export bans on advanced GPUs to China. Getting a GPU at the right power to sell in China can be a difficult task. Nvidia tried this already with its MI308 GPU, but it proved to be too powerful to sell in the country. That cost it hundreds of millions of dollars, a mistake that AMD will likely go to great lengths to avoid. Still, it has to sell a GPU similar in power to Nvidia's Chinese offerings to attract customers. This complicates matters and puts AMD in a tough position. AMD Analyst Upgrade In other recent news, AMD stock shrugged off its only Sell rating earlier this week. Four-star HSBC analyst Frank Lee upgraded the semiconductor company's shares to Hold but didn't offer a price target. AMD stock was down 1.77% on Friday, building on an 8.08% drop year-to-date. The company's shares have also fallen 32.3% over the past 12 months. Is AMD Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for AMD is Moderate Buy, based on 22 Buy and 10 Hold ratings over the past three months. With that comes an average AMD stock price target of $126.55, representing a potential 14.05% upside for the shares.
Business Insider
4 hours ago
- Business Insider
Winners and Losers: Energy Stocks Soared and Healthcare Crashed in May
May was a month to remember for the U.S. stock market as the benchmark S&P 500 index posted a gain of 6% and had its best showing since 1990. But, as always, there were winners and losers among equities. Confident Investing Starts Here: The big winners among U.S. stocks during May were energy and technology stocks that are helping to power the artificial intelligence (AI) revolution. Specifically, NRG Energy (NRG) saw its share price rise 42% in the month and Constellation Energy (CEG) was close behind with a 37% gain. Both companies power AI data centers through cleaner energy sources such as natural gas. Other big winners in May were previously downtrodden technology stocks that are also associated with AI. These include data storage firm Seagate Technology (STX), whose share price increased 37% and outpaced AI chipmaker Nvidia (NVDA). Super Micro Computer (SMCI), which makes AI servers that run Nvidia microchips, also had a big month, with its stock running 26% higher. Healthcare Loses Out On the flipside, healthcare was the worst-performing sector of the market in May. The declines were led by insurer UnitedHealth Group (UNH), whose share price fell 27% amid worries after the company slashed its full-year guidance. Also dragging healthcare lower was pharmaceutical giant Eli Lilly (LLY), whose stock dropped 18% after the Trump administration said it wants prescription drug prices lower. Other healthcare stocks that took a drubbing in May include retail pharmacy chain CVS Health (CVS), and healthcare insurer Humana (HUM). The lone bright spot among healthcare stocks was Insulet (PODD), whose share price vaulted 29% higher on strong financial results. The stock has been on an upswing since the U.S. Food and Drug Administration (FDA) approved its insulin system for Type 2 Diabetes last summer. Is LLY Stock a Buy? The stock of Eli Lilly has a consensus Strong Buy recommendation among 18 Wall Street analysts. That rating is based on 16 Buy, one Hold, and one Sell recommendations issued in the last 12 months. The average LLY price target of $1,003.14 implies 34.82% upside from current levels.
